Articles published by Johnson & Johnson
Johnson & Johnson to Participate in the Bernstein 39th Annual Strategic Decisions Conference
April 25, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson Announces Dividend Increase of 5.3%
April 18, 2023
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Reports Q1 2023 Results
April 18, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature
March 15, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson Announces Pricing of $7.75 Billion of Senior Notes Issued by Kenvue Inc.
March 08, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson Names Paula A. Johnson, President of Wellesley College, to its Board of Directors
February 14, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D
February 13, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson Reports Q4 and Full-Year 2022 Results
January 24, 2023
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Completes Acquisition of Abiomed
December 22, 2022
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson Announces Extension of Abiomed Tender Offer to December 21, 2022
December 14, 2022
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the 41st Annual J.P. Morgan Healthcare Conference
December 07, 2022
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board
November 30, 2022
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Reports Q3 2022 Results
October 18, 2022
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference
October 03, 2022
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company
September 28, 2022
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson Opens State-of-the-Art Science and Technology Campus in San Francisco Bay Area
September 20, 2022
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson Announces $5 Billion Share Repurchase Program
September 14, 2022
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
September 13, 2022
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson Appoints Larry Merlo as Non-Executive Chair Designate of Planned New Consumer Health Company
August 24, 2022
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
August 09, 2022
From Johnson & Johnson
Via Business Wire
Tickers
JNJ
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free